Aytu stock buy or sell.
Complete Aytu BioPharma Inc.
Aytu stock buy or sell We aim to bring you long-term focused analysis driven by fundamental data. 80% in the past 2 days. 31% institutional shareholders, 481. (AYTU) stock price quote with breaking news, financials, statistics, charts and more. Bullish Indicators Bearish Indicators Mar 25, 2020 · Get the latest Aytu BioPharma Inc. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $19. 00% retail investors. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. stock information by Barron's. Jan 22, 2025 · See the latest Aytu BioPharma Inc stock price (AYTU:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Aytu BioPharma, Inc. You can watch AYTUP and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. The advice algorithm takes into account all of Aytu BioScience's available fundamental , technical, and predictive indicators you will find on this site. Looking to buy Aytu BioScience Stock? View today's AYTU stock price, trade commission-free, and discuss AYTU stock updates with the investor community. This represents an increase of 357. Macroaxis provides Aytu BioScience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AYTU positions. 57M beats by $2. If you had invested in Aytu Biopharma stock at $22,600. 75. . 16% of the company. stock was originally listed at a price of $22,600. 30 - $2. Aytu Biopharma (NASDAQ: AYTU) is owned by 33. Jan 1, 2023 · Start Time: 16:30 January 1, 0000 5:12 PM ET Aytu BioPharma, Inc. AYTU Stock Predictions. Get the latest chart with broker recommendations from Zacks Investment Research. 00, your return over the last 7 years would have been -99. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score 6 days ago · Should You Buy or Sell Aytu BioPharma Stock? Get The Latest AYTU Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Aytu BioScience (AYTU) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. Find stocks hotter than AYTU? Today's trending stocks Momentum & breakout stocks 100% Free, Limited Time Only! Free Signup. Should I View today's Aytu BioScience Inc stock price and latest AYTU news and analysis. 7% (not including any dividends or dividend reinvestments). and a bulleted list of reasons to buy or sell the stock. We aim to bring you long-term focused analysis driven Complete Aytu BioPharma Inc. Create real-time notifications to follow any changes in the live stock price. View the AYTU premarket stock price ahead of the market session or assess the after hours quote. Jan 16, 2024 · It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. The AYTU stock forecast is provided by MarketClub with their Trade Triangle system. (AYTU) Q1 2025 Earnings Call Transcript: Nov 13: Aytu BioPharma GAAP EPS of -$0. AYTU is trading in the range of $2. (NASDAQ:AYTU ) Q4 2022 Earnings Conference Call September 27, 2022, 16:30 PM ET Company Participants Josh Disbrow - Chairman and CEO Mark Oki - CFO Robert Blum - Lytham Partners Conference Call Participants Vernon Bernardino - H. Only one brokerage firm provided 2 days ago · Get the latest Aytu BioPharma Inc AYTU detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. C. Monitor the latest movements within the Aytu BioScience Inc real time stock price chart below. View real-time AYTU stock price and news, along with industry-best analysis. View the real-time AYTU price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aytu BioScience Preferred against related stocks people have also bought. (AYTU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11. 6 days ago · As an investor, you want to buy stocks with the highest probability of success. 8M: Nov 13: Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Apr 14, 2020 · Aytu Bioscience, Inc. 01% Aytu Biopharma insiders, and 0. , a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. 00 in Oct 20, 2017. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. Sell : 209 : Restricted Jan 17, 2025 · Get a real-time Aytu BioPharma, Inc. AYTU is down -17. is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how (AYTU) grades on certain investment factors and determine whether it meets your investment needs. (AYTU) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. 99%, for an annualized return of -74. Nov 14, 2024 · Learn more about whether Aytu BioPharma, Inc. (AYTU) stock quote, history, news and other vital information to help you with your stock trading and investing. It Dec 27, 2024 · It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. An upward trend in earnings estimates -- one of the most powerful Aytu BioScience Inc stock price live, this page displays NASDAQ AYTU stock exchange data. Jan 17, 2025 · Only one analyst offered a short-term price target of $8. 67M. Top 50 Stocks Today! AYTU Buy or Sell? AYTU Buy or Sell? Find out if you should buy AYTU stock. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell. 19% on 09/27/24. AYTU Stock Price (OTCMKTS), Forecast, Predictions, Stock Analysis and Aytu Bioscience News. Thinking of buying or selling Aytu BioScience Inc stock that’s listed in a currency different from your local one? Use our international stock ticker to check and convert stocks and shares easily in any currency you need. Find the latest Aytu BioPharma, Inc. 14% from the last closing price of $1. 08M shares representing 180. AYTU is up 0. Apr 14, 2020 · The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell Buy Aytu BioScience Inc NASDAQ:AYTU stock? Extensive information, signals, indicators to help you decide if to buy or sell your stock. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Should I buy AYTU stock? AYTU Stock Analysis. Jan 22, 2025 · Check if AYTU Stock has a Buy or Sell Evaluation. AYTU: Aytu BioPharma broker recommendation chart. 85 in the past 30 days. 14, revenue of $16. 00% on 01/27/25 and has gained a total of 1. Wainwright Sumant Kulkarni - Canaccord Operator Good afternoon everyone and welcome to Aytu Dec 25, 2024 · Aytu Biopharma. 00 for Aytu BioPharma Inc. 20 beats by $0. Get a free AYTU technical analysis report to make a better AYTU stock predictions on how the stock will perform in the near future. Jan 21, 2025 · Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029 ; Period Ending Jun 30, 2020 Jun 30, 2021 Jun 30, 2022 Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive Nov 14: Aytu BioPharma, Inc. vcptckbdqjtiggekwvhmboigjecjmgydpjqblsxvp